6-mercaptopurine
TPMT genotype
acute lymphoblastic leukemia
myelotoxicity
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
11 Aug 2021
11 Aug 2021
Historique:
received:
01
07
2021
revised:
05
08
2021
accepted:
09
08
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
The response to 6-mercaptopurine (6-MP) can be altered by genetic polymorphisms in genes encoding drug-metabolizing enzymes and drug transporters. The purpose of this study was to investigate the association between genetic polymorphisms of drug-metabolizing enzymes (
Identifiants
pubmed: 34442427
pii: jpm11080783
doi: 10.3390/jpm11080783
pmc: PMC8400562
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Pharmacogenetics. 2002 Apr;12(3):191-5
pubmed: 11927834
Pharmacogenetics. 1999 Feb;9(1):37-42
pubmed: 10208641
Clin Ther. 2009 Jul;31(7):1524-33
pubmed: 19695401
Pediatr Blood Cancer. 2011 Oct;57(4):578-82
pubmed: 21319286
Genomics Proteomics Bioinformatics. 2017 Apr;15(2):82-93
pubmed: 28391009
Br J Clin Pharmacol. 2004 Jul;58(1):66-70
pubmed: 15206995
Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):497-505
pubmed: 31103474
Br J Clin Pharmacol. 2011 Apr;71(4):575-84
pubmed: 21395650
Leuk Lymphoma. 2012 May;53(5):891-900
pubmed: 21988642
Leuk Res. 2010 Aug;34(8):1023-6
pubmed: 20153897
J Clin Pharm Ther. 2012 Apr;37(2):237-41
pubmed: 21545474
J Pediatr Hematol Oncol. 2017 Apr;39(3):161-166
pubmed: 28060115
Med Pediatr Oncol. 2000 Oct;35(4):410-4
pubmed: 11025471
Pharmacogenetics. 2004 Mar;14(3):181-7
pubmed: 15167706
Cancer Res. 2008 Jul 1;68(13):4983-9
pubmed: 18593894
Br J Clin Pharmacol. 2008 Oct;66(4):517-28
pubmed: 18662289
Lancet Oncol. 2017 Apr;18(4):515-524
pubmed: 28258828
J Natl Cancer Inst. 1999 Dec 1;91(23):2001-8
pubmed: 10580024
Curr Hematol Malig Rep. 2017 Jun;12(3):176-186
pubmed: 28317081
J Gastroenterol. 2010 Oct;45(10):1014-21
pubmed: 20393862
Blood Rev. 2015 Jul;29(4):243-9
pubmed: 25614322
Eur J Clin Pharmacol. 2008 Apr;64(4):373-9
pubmed: 18193212
N Engl J Med. 2015 Oct 15;373(16):1541-52
pubmed: 26465987
Pharmacogenomics. 2020 Apr;21(6):403-410
pubmed: 32308129
Lancet. 2013 Jun 1;381(9881):1943-55
pubmed: 23523389
Blood Cancer J. 2017 Jun 30;7(6):e577
pubmed: 28665419
Pharmacogenomics J. 2015 Aug;15(4):380-4
pubmed: 25403995
PLoS Curr. 2011 May 15;3:RRN1236
pubmed: 21593964
Clin Chim Acta. 2006 Mar;365(1-2):337-41
pubmed: 16223474
Clin Pharmacol Ther. 2013 Apr;93(4):324-5
pubmed: 23422873